Ramis Colak’s scientific contributions

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (1)


The mean (± SE) values for the patients’ FM/BW at the beginning of the study (basal) and after 4 weeks, 8 weeks, and 12 weeks.
The mean (± SE) values for the patients’ FFM/BW at the beginning of the study (week 0) and after 4 weeks, 8 weeks, and 12 weeks for the orlistat–exercise group (black) and the orlistat group (white).
The mean (± SE) values for the patients’ Wmax/BW (W/kg) at the beginning of the study (basal) and after 4 weeks, 8 weeks, and 12 weeks for the orlistat group (white) and the orlistat–exercise group (black).
Beneficial effects of training at the anaerobic threshold in addition to pharmacotherapy on weight loss, body composition, and exercise performance in women with obesity
  • Article
  • Full-text available

July 2015

·

100 Reads

·

27 Citations

Oguz Ozcelik

·

Yusuf Ozkan

·

·

Ramis Colak

Objective The aim of this study was to determine and compare the effects of weight loss achieved through orlistat therapy alone or a combination of orlistat and an aerobic exercise training program on aerobic fitness and body composition in obese females. Methods Twenty-eight obese patients were randomly assigned to receive 12-week treatment with hypocaloric diet–orlistat or diet–orlistat–exercise. Each participant performed an incremental ramp exercise test every 4 weeks to measure aerobic fitness. Fourteen participants performed continuous exercise (approximately 45 minutes per session) at a work rate corresponding to the anaerobic threshold three times per week. Results A decrease in the fat mass to body weight ratio of 3.8% (P=0.006) was observed at the end of the 12 weeks in the orlistat group, while a decrease of 9.5% (P=0.001) was seen in the orlistat–exercise group. Maximal exercise capacity increased by 46.5% in the orlistat–exercise group and by 19.5% in the orlistat group. Conclusion While orlistat therapy resulted in an improvement in body composition and aerobic fitness at the end of the 12-week period, its combination with exercise training provided improvements in the same parameters within the first 4 weeks of the study. These additional beneficial effects of combining aerobic exercise with orlistat therapy are important with regards to obesity-associated risk factors.

Download

Citations (1)


... The main reason to exclude intervention was the absence of a group-treated anti-obesity drug without exercise training, or due to a lack of exercise training intervention. A total of four studies [22][23][24][25] met the inclusion criteria, providing data from 202 participants ( Figure 1). Details of the studies excluded during full-text screening, along with the reasons for their exclusion, are presented in Supplementary Material 2. ...

Reference:

Anti-obesity drugs alone or combined with exercise training in the management of obesity: a systematic review with meta-analysis
Beneficial effects of training at the anaerobic threshold in addition to pharmacotherapy on weight loss, body composition, and exercise performance in women with obesity